<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35628504</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5694</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23105694</ELocationID><Abstract><AbstractText>Mutations in profilin 1 (PFN1) have been identified in rare familial cases of Amyotrophic Lateral Sclerosis (ALS). PFN1 is involved in multiple pathways that could intervene in ALS pathology. However, the specific pathogenic role of PFN1 mutations in ALS is still not fully understood. We hypothesized that PFN1 could play a role in regulating autophagy pathways and that PFN1 mutations could disrupt this function. We used patient cells (lymphoblasts) or tissue (post-mortem) carrying PFN1 mutations (M114T and E117G), and designed experimental models expressing wild-type or mutant PFN1 (cell lines and novel PFN1 mice established by lentiviral transgenesis) to study the effects of PFN1 mutations on autophagic pathway markers. We observed no accumulation of PFN1 in the spinal cord of one E117G mutation carrier. Moreover, in patient lymphoblasts and transfected cell lines, the M114T mutant PFN1 protein was unstable and deregulated the RAB9-mediated alternative autophagy pathway involved in the clearance of damaged mitochondria. In vivo, motor neurons expressing M114T mutant PFN1 showed mitochondrial abnormalities. Our results demonstrate that the M114T PFN1 mutation is more deleterious than the E117G variant in patient cells and experimental models and suggest a role for the RAB9-dependent autophagic pathway in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teyssou</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chartier</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roussel</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4644-7679</Identifier><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Nirma D</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0002-7695-6290</Identifier><AffiliationInfo><Affiliation>The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemazanyy</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8080-839X</Identifier><AffiliationInfo><Affiliation>Platform for Metabolic Analyses, Structure F&#xe9;d&#xe9;rative de Recherche Necker, INSERM US24/CNRS UAR 3633, F-75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langui</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5484-2359</Identifier><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>M&#xe9;lanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larmonier</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Banque d'ADN et de Cellules du G&#xe9;n&#xe9;thon, F-91000 Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saker</LastName><ForeName>Safaa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Banque d'ADN et de Cellules du G&#xe9;n&#xe9;thon, F-91000 Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salachas</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de R&#xe9;f&#xe9;rence SLA Ile de France, D&#xe9;partement de Neurologie, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, APHP, DMU Neuroscience, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pradat</LastName><ForeName>Pierre-Fran&#xe7;ois</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Centre de R&#xe9;f&#xe9;rence SLA Ile de France, D&#xe9;partement de Neurologie, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, APHP, DMU Neuroscience, F-75013 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale, Sorbonne Universit&#xe9;, INSERM UMRS1146, CNRS UMR7371, F-75013 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute Ulster University, C-TRIC, Altnagelvin Hospital, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meininger</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>H&#xf4;pital des Peupliers, Ramsay G&#xe9;n&#xe9;rale de Sant&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravassard</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xf4;t&#xe9;</LastName><ForeName>Francine</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut Cochin, INSERM U1016, CNRS UMR8104, Universit&#xe9; de Paris, F-75014 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobsiger</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boill&#xe9;e</LastName><ForeName>S&#xe9;verine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0001-6580-7655</Identifier><AffiliationInfo><Affiliation>The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seilhean</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHP, D&#xe9;partement de Neuropathologie, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, DMU Neuroscience, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millecamps</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0745-6735</Identifier><AffiliationInfo><Affiliation>Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Sorbonne Universit&#xe9;, F-75013 Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R11010DD, R17050DD &amp;amp; S.3200.ARSLA.1</GrantID><Agency>Association pour la recherche sur la Scl&#xe9;rose Lat&#xe9;rale Amyotrophique</Agency><Country/></Grant><Grant><GrantID>#19466 &amp;amp; #19466</GrantID><Agency>Association Fran&#xe7;aise contre les Myopathies</Agency><Country/></Grant><Grant><GrantID>R16009DD</GrantID><Agency>Aide &#xe0; la Recherche des Maladies du Cerveau association</Agency><Country/></Grant><Grant><GrantID>AO-FRC 2009 #33536</GrantID><Agency>F&#xe9;d&#xe9;ration pour la Recherche sur le Cerveau</Agency><Country/></Grant><Grant><Agency>Stafford Fox Medical Research Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495738">PFN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495739">Pfn1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051304">Profilins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C079856">RAB9A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C544263">rab9 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020691">rab GTP-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051304" MajorTopicYN="Y">Profilins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020691" MajorTopicYN="Y">rab GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">NSC-34 cell line</Keyword><Keyword MajorTopicYN="N">RAB9</Keyword><Keyword MajorTopicYN="N">alternative autophagy</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">lymphoblasts</Keyword><Keyword MajorTopicYN="N">mitochondrial homeostasis</Keyword><Keyword MajorTopicYN="N">mutations</Keyword><Keyword MajorTopicYN="N">post-mortem spinal cord</Keyword><Keyword MajorTopicYN="N">transgenic mice</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35628504</ArticleId><ArticleId IdType="pmc">PMC9143529</ArticleId><ArticleId IdType="doi">10.3390/ijms23105694</ArticleId><ArticleId IdType="pii">ijms23105694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weishaupt J.H., Hyman T., Dikic I. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Trends Mol. Med. 2016;22:769&#x2013;783. doi: 10.1016/j.molmed.2016.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.07.005</ArticleId><ArticleId IdType="pubmed">27498188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Baker M.C., Bieniek K.F., Knopman D.S., Josephs K.A., Boeve B., Caselli R., Wszolek Z.K., Petersen R., Graff-Radford N.R., et al. Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14:463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3923463</ArticleId><ArticleId IdType="pubmed">23634771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., van Doormaal P.T., Dekker A.M., Ticozzi N., Kenna B.J., Diekstra F.P., van Rheenen W., van Eijk K.R., Jones A.R., Keagle P., et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Landers J.E., Rizik N., Volk A.E., Akimoto C., Birve A., Hubers A., Keagle P.J., Piotrowska K., Press R., et al. A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol. Aging. 2013;34:1708.e1&#x2013;1708.e6. doi: 10.1016/j.neurobiolaging.2012.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.10.009</ArticleId><ArticleId IdType="pmc">PMC6591725</ArticleId><ArticleId IdType="pubmed">23141414</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Zheng Z.Z., Huang R., Chen K., Song W., Zhao B., Chen X., Yang Y., Yuan L., Shang H.F. PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:1922.e1&#x2013;1922.e5. doi: 10.1016/j.neurobiolaging.2013.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.01.013</ArticleId><ArticleId IdType="pubmed">23428184</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Vance C., Scotter E.L., Troakes C., Wong C.H., Topp S., Maekawa S., King A., Mitchell J.C., Lund K., et al. Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiol. Aging. 2015;36:1602.e17&#x2013;1602.e27. doi: 10.1016/j.neurobiolaging.2014.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4357530</ArticleId><ArticleId IdType="pubmed">25499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Chen S.D., Feng S.Y., Liu C.Y., Cui M., Chen S.F., Feng S.M., Dong Q., Huang H., Yu J.T. Familial flail leg ALS caused by PFN1 mutation. J. Neurol. Neurosurg. Psychiatry. 2020;91:223&#x2013;224. doi: 10.1136/jnnp-2019-321366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321366</ArticleId><ArticleId IdType="pubmed">31401564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi J., Chen J., Li Y., Huang Z., Wang L., Zhang Y. A Familial Phenotypic and Genetic Study of Mutations in PFN1 Associated with Amyotrophic Lateral Sclerosis. Neurosci. Bull. 2020;36:174&#x2013;178. doi: 10.1007/s12264-019-00448-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-019-00448-8</ArticleId><ArticleId IdType="pmc">PMC6977784</ArticleId><ArticleId IdType="pubmed">31802421</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutt C.E., Myslik J.C., Rozycki M.D., Goonesekere N.C., Lindberg U. The structure of crystalline profilin-beta-actin. Nature. 1993;365:810&#x2013;816. doi: 10.1038/365810a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/365810a0</ArticleId><ArticleId IdType="pubmed">8413665</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzler W.J., Bell A.J., Ernst E., Lavoie T.B., Mueller L. Identification of the poly-L-proline-binding site on human profilin. J. Biol. Chem. 1994;269:4620&#x2013;4625. doi: 10.1016/S0021-9258(17)41821-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)41821-7</ArticleId><ArticleId IdType="pubmed">8308034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovar D.R., Harris E.S., Mahaffy R., Higgs H.N., Pollard T.D. Control of the assembly of ATP- and ADP-actin by formins and profilin. Cell. 2006;124:423&#x2013;435. doi: 10.1016/j.cell.2005.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.11.038</ArticleId><ArticleId IdType="pubmed">16439214</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt E.J., Funes S., McKeon J.E., Morgan B.R., Boopathy S., O&#x2019;Connor L.C., Bilsel O., Massi F., Jegou A., Bosco D.A. ALS-linked PFN1 variants exhibit loss and gain of functions in the context of formin-induced actin polymerization. Proc. Natl. Acad. Sci. USA. 2021;118:e2024605118. doi: 10.1073/pnas.2024605118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024605118</ArticleId><ArticleId IdType="pmc">PMC8201830</ArticleId><ArticleId IdType="pubmed">34074767</ArticleId></ArticleIdList></Reference><Reference><Citation>Boopathy S., Silvas T.V., Tischbein M., Jansen S., Shandilya S.M., Zitzewitz J.A., Landers J.E., Goode B.L., Schiffer C.A., Bosco D.A. Structural basis for mutation-induced destabilization of profilin 1 in ALS. Proc. Natl. Acad. Sci. USA. 2015;112:7984&#x2013;7989. doi: 10.1073/pnas.1424108112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424108112</ArticleId><ArticleId IdType="pmc">PMC4491777</ArticleId><ArticleId IdType="pubmed">26056300</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Schopflin M., Feiler M.S., Fleck A.K., Ludolph A.C., Weishaupt J.H. Profilin 1 with the amyotrophic lateral sclerosis associated mutation T109M displays unaltered actin binding and does not affect the actin cytoskeleton. BMC Neurosci. 2015;1677:77. doi: 10.1186/s12868-015-0214-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-015-0214-y</ArticleId><ArticleId IdType="pmc">PMC4647582</ArticleId><ArticleId IdType="pubmed">26572741</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Poggetto E., Gori L., Chiti F. Biophysical analysis of three novel profilin-1 variants associated with amyotrophic lateral sclerosis indicates a correlation between their aggregation propensity and the structural features of their globular state. Biol. Chem. 2016;397:927&#x2013;937. doi: 10.1515/hsz-2016-0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2016-0154</ArticleId><ArticleId IdType="pubmed">27101547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekouei M., Ghezellou P., Aliahmadi A., Arjmand S., Kiaei M., Ghassempour A. Changes in biophysical characteristics of PFN1 due to mutation causing amyotrophic lateral sclerosis. Metab. Brain Dis. 2018;33:1975&#x2013;1984. doi: 10.1007/s11011-018-0305-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-018-0305-4</ArticleId><ArticleId IdType="pmc">PMC6230493</ArticleId><ArticleId IdType="pubmed">30203378</ArticleId></ArticleIdList></Reference><Reference><Citation>Henty-Ridilla J.L., Juanes M.A., Goode B.L. Profilin Directly Promotes Microtubule Growth through Residues Mutated in Amyotrophic Lateral Sclerosis. Curr. Biol. 2017;27:3535&#x2013;3543.e4. doi: 10.1016/j.cub.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2017.10.002</ArticleId><ArticleId IdType="pmc">PMC5772683</ArticleId><ArticleId IdType="pubmed">29129529</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Nonaka T., Suzuki G., Kametani F., Hasegawa M. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Hum. Mol. Genet. 2016;25:1420&#x2013;1433. doi: 10.1093/hmg/ddw024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw024</ArticleId><ArticleId IdType="pubmed">26908597</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampetruzzi A., Danielson E.W., Gumina V., Jeon M., Boopathy S., Brown R.H., Ratti A., Landers J.E., Fallini C. Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis. Nat. Commun. 2019;10:3827. doi: 10.1038/s41467-019-11837-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11837-y</ArticleId><ArticleId IdType="pmc">PMC6707192</ArticleId><ArticleId IdType="pubmed">31444357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.H., Giampetruzzi A., Tran H., Fallini C., Gao F.B., Landers J.E. A Drosophila model of ALS reveals a partial loss of function of causative human PFN1 mutants. Hum. Mol. Genet. 2017;26:2146&#x2013;2155. doi: 10.1093/hmg/ddx112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx112</ArticleId><ArticleId IdType="pmc">PMC6251673</ArticleId><ArticleId IdType="pubmed">28379367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D., DeLoach A., Yadav S., Alkam D., MacNicol M., Singh A., Compadre C.M., Goellner J.J., O&#x2019;Brien C.A., Fahmi T., et al. Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum. Mol. Genet. 2017;26:686&#x2013;701. doi: 10.1093/hmg/ddw429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw429</ArticleId><ArticleId IdType="pmc">PMC5968635</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Danielson E.W., Qiao T., Metterville J., Brown R.H., Jr., Landers J.E., Xu Z. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proc. Natl. Acad. Sci. USA. 2016;113:E6209&#x2013;E6218. doi: 10.1073/pnas.1605964113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605964113</ArticleId><ArticleId IdType="pmc">PMC5068285</ArticleId><ArticleId IdType="pubmed">27681617</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan G., Cui S., Chen X., Song H., Huang C., Tong J., Yuan Z., Yu L., Xiong X., Zhao J., et al. Detergent-insoluble inclusion constitutes the first pathology in PFN1 transgenic rats. J. Neurochem. 2021;157:1244&#x2013;1252. doi: 10.1111/jnc.15139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15139</ArticleId><ArticleId IdType="pmc">PMC8994973</ArticleId><ArticleId IdType="pubmed">32754913</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettle M., Stefen H., Djordjevic A., Fok S.Y.Y., Chan J.W., van Hummel A., van der Hoven J., Przybyla M., Volkerling A., Ke Y.D., et al. Developmental Expression of Mutant PFN1 in Motor Neurons Impacts Neuronal Growth and Motor Performance of Young and Adult Mice. Front. Mol. Neurosci. 2019;12:231. doi: 10.3389/fnmol.2019.00231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00231</ArticleId><ArticleId IdType="pmc">PMC6776973</ArticleId><ArticleId IdType="pubmed">31611772</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W., Sutherland J.D., Sharpe A., Arai M., Kwiatkowski D.J. Profilin I is essential for cell survival and cell division in early mouse development. Proc. Natl. Acad. Sci. USA. 2001;98:3832&#x2013;3836. doi: 10.1073/pnas.051515498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051515498</ArticleId><ArticleId IdType="pmc">PMC31138</ArticleId><ArticleId IdType="pubmed">11274401</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004;14:461&#x2013;469. doi: 10.1016/j.tcb.2004.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2004.07.003</ArticleId><ArticleId IdType="pubmed">15308213</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M.D., Bieri G., Kolaitis R.M., Taylor J.P., Gitler A.D. Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J. Neurosci. 2014;34:8083&#x2013;8097. doi: 10.1523/JNEUROSCI.0543-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0543-14.2014</ArticleId><ArticleId IdType="pmc">PMC4051967</ArticleId><ArticleId IdType="pubmed">24920614</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W., Podtelejnikov A.V., Di Nardo A., Sutherland J.D., Gurniak C.B., Dotti C., Mann M. In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly. EMBO J. 1998;17:967&#x2013;976. doi: 10.1093/emboj/17.4.967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.4.967</ArticleId><ArticleId IdType="pmc">PMC1170446</ArticleId><ArticleId IdType="pubmed">9463375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010;6:217&#x2013;227. doi: 10.4161/auto.6.2.11014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.2.11014</ArticleId><ArticleId IdType="pmc">PMC2929010</ArticleId><ArticleId IdType="pubmed">20104022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A.H., Manna S.K. Profilin-PTEN interaction suppresses NF-kappaB activation via inhibition of IKK phosphorylation. Biochem. J. 2016;473:859&#x2013;872. doi: 10.1042/BJ20150624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20150624</ArticleId><ArticleId IdType="pubmed">26787927</ArticleId></ArticleIdList></Reference><Reference><Citation>Arico S., Petiot A., Bauvy C., Dubbelhuis P.F., Meijer A.J., Codogno P., Ogier-Denis E. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 2001;276:35243&#x2013;35246. doi: 10.1074/jbc.C100319200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C100319200</ArticleId><ArticleId IdType="pubmed">11477064</ArticleId></ArticleIdList></Reference><Reference><Citation>Seilhean D., Cazeneuve C., Thuries V., Russaouen O., Millecamps S., Salachas F., Meininger V., Leguern E., Duyckaerts C. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol. 2009;118:561&#x2013;573. doi: 10.1007/s00401-009-0545-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0545-9</ArticleId><ArticleId IdType="pubmed">19449021</ArticleId></ArticleIdList></Reference><Reference><Citation>Seilhean D., Takahashi J., El Hachimi K.H., Fujigasaki H., Lebre A.S., Biancalana V., Durr A., Salachas F., Hogenhuis J., de The H., et al. Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol. 2004;108:81&#x2013;87. doi: 10.1007/s00401-004-0855-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0855-x</ArticleId><ArticleId IdType="pubmed">15114487</ArticleId></ArticleIdList></Reference><Reference><Citation>Das T., Bae Y.H., Wells A., Roy P. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells. J. Cell. Physiol. 2009;218:436&#x2013;443. doi: 10.1002/jcp.21618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.21618</ArticleId><ArticleId IdType="pmc">PMC2874249</ArticleId><ArticleId IdType="pubmed">18937284</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S. Biological Roles of Alternative Autophagy. Mol. Cells. 2018;41:50&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5792713</ArticleId><ArticleId IdType="pubmed">29370693</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S., Arakawa S., Nishida Y. Autophagy takes an alternative pathway. Autophagy. 2010;6:290&#x2013;291. doi: 10.4161/auto.6.2.11127.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.2.11127</ArticleId><ArticleId IdType="pubmed">20104021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720&#x2013;5728. doi: 10.1093/emboj/19.21.5720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/19.21.5720</ArticleId><ArticleId IdType="pmc">PMC305793</ArticleId><ArticleId IdType="pubmed">11060023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida Y., Arakawa S., Fujitani K., Yamaguchi H., Mizuta T., Kanaseki T., Komatsu M., Otsu K., Tsujimoto Y., Shimizu S. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature. 2009;461:654&#x2013;658. doi: 10.1038/nature08455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08455</ArticleId><ArticleId IdType="pubmed">19794493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.J., Chen S., Huang K.X., Le W.D. Why should autophagic flux be assessed? Acta Pharmacol. Sin. 2013;34:595&#x2013;599. doi: 10.1038/aps.2012.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2012.184</ArticleId><ArticleId IdType="pmc">PMC4002868</ArticleId><ArticleId IdType="pubmed">23474710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii S.R., Mizushima N. Monitoring and Measuring Autophagy. Int. J. Mol. Sci. 2017;18:1865. doi: 10.3390/ijms18091865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091865</ArticleId><ArticleId IdType="pmc">PMC5618514</ArticleId><ArticleId IdType="pubmed">28846632</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanida I., Minematsu-Ikeguchi N., Ueno T., Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84&#x2013;91. doi: 10.4161/auto.1.2.1697.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.1.2.1697</ArticleId><ArticleId IdType="pubmed">16874052</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskey D., Yousefi S., Schmid I., Zlobec I., Perren A., Friis R., Simon H.U. ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy. Nat. Commun. 2013;4:2130. doi: 10.1038/ncomms3130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3130</ArticleId><ArticleId IdType="pmc">PMC3753548</ArticleId><ArticleId IdType="pubmed">23945651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon A.H., Hart P.D., Young M.R. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature. 1980;286:79&#x2013;80. doi: 10.1038/286079a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/286079a0</ArticleId><ArticleId IdType="pubmed">6993961</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S., Honda S., Arakawa S., Yamaguchi H. Alternative macroautophagy and mitophagy. Int. J. Biochem. Cell Biol. 2014;50:64&#x2013;66. doi: 10.1016/j.biocel.2014.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2014.02.016</ArticleId><ArticleId IdType="pubmed">24569119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota Y., Yamashita S., Kurihara Y., Jin X., Aihara M., Saigusa T., Kang D., Kanki T. Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. 2015;11:332&#x2013;343. doi: 10.1080/15548627.2015.1023047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1023047</ArticleId><ArticleId IdType="pmc">PMC4502654</ArticleId><ArticleId IdType="pubmed">25831013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 1989;119:203&#x2013;210. doi: 10.1016/0022-1759(89)90397-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(89)90397-9</ArticleId><ArticleId IdType="pubmed">2470825</ArticleId></ArticleIdList></Reference><Reference><Citation>Dussaud S., Pardanaud-Glavieux C., Sauty-Colace C., Ravassard P. Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders. J. Vis. Exp. 2018;7:e57609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6235436</ArticleId><ArticleId IdType="pubmed">30346378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennel P.F., Finiels F., Revah F., Mallet J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: An electromyographic study. Neuroreport. 1996;7:1427&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pubmed">8856691</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M., Leclerc N., Gurney M., Warter J.M., Poindron P., Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:45&#x2013;51. doi: 10.1002/(SICI)1097-4598(199701)20:1&lt;45::AID-MUS6&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199701)20:1&lt;45::AID-MUS6&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">8995582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Charnock J., Collins T., Devoy A., Howard R., Malaspina A., Orrell R., Sidle K., Clarke J., Shoai M., et al. Profilin1 E117G is a moderate risk factor for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2014;85:506&#x2013;508. doi: 10.1136/jnnp-2013-306761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306761</ArticleId><ArticleId IdType="pmc">PMC3995330</ArticleId><ArticleId IdType="pubmed">24309268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Fifita J.A., Williams K.L., Warraich S.T., Pamphlett R., Nicholson G.A., Blair I.P. Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:2235.e7&#x2013;2235.e10. doi: 10.1016/j.neurobiolaging.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.04.003</ArticleId><ArticleId IdType="pubmed">23635659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiloca C., Ticozzi N., Pensato V., Corrado L., Del Bo R., Bertolin C., Fenoglio C., Gagliardi S., Calini D., Lauria G., et al. Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiol. Aging. 2013;34:1517.e9&#x2013;1517.e10. doi: 10.1016/j.neurobiolaging.2012.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.016</ArticleId><ArticleId IdType="pmc">PMC3548975</ArticleId><ArticleId IdType="pubmed">23063648</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., et al. ANG mutations segregate with familial and &#x2018;sporadic&#x2019; amyotrophic lateral sclerosis. Nat. Genet. 2006;38:411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Boillee S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., Moigneu C., Vandenberghe N., Danel-Brunaud V., Corcia P., et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J. Med. Genet. 2012;49:258&#x2013;263. doi: 10.1136/jmedgenet-2011-100699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2011-100699</ArticleId><ArticleId IdType="pubmed">22499346</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J., Allred P., Bali T., Pestronk A., Goate A., Miller T.M., Mitra R.D., Ravits J., Harms M.B., Baloh R.H. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann. Neurol. 2015;77:100&#x2013;113. doi: 10.1002/ana.24306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Ciura S., Rouleau G.A., Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) Trends Genet. 2015;31:263&#x2013;273. doi: 10.1016/j.tig.2015.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2015.03.005</ArticleId><ArticleId IdType="pubmed">25869998</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Hennekam E.A., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.S., Holzbaur E.L.F. Autophagy and mitophagy in ALS. Neurobiol. Dis. 2019;122:35&#x2013;40. doi: 10.1016/j.nbd.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.005</ArticleId><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Bel Hadj S., Zandona A., Julien J.P., Shah S.B., Cleveland D.W. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS ONE. 2011;6:e22031. doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Destroismaisons L., Peyrard S.L., Cadot S., Rouleau G.A., Brown R.H., Jr., Julien J.P., Arbour N., Vande Velde C. Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 2013;22:3947&#x2013;3959. doi: 10.1093/hmg/ddt249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt249</ArticleId><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A.S., Wong Y.C., Simpson C.L., Holzbaur E.L. Dynamic actin cycling through mitochondrial subpopulations locally regulates the fission-fusion balance within mitochondrial networks. Nat. Commun. 2016;7:12886. doi: 10.1038/ncomms12886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12886</ArticleId><ArticleId IdType="pmc">PMC5056443</ArticleId><ArticleId IdType="pubmed">27686185</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Xie E.F., Kocak N., Ozdinler P.H. Mitoautophagy: A Unique Self-Destructive Path Mitochondria of Upper Motor Neurons With TDP-43 Pathology Take, Very Early in ALS. Front. Cell. Neurosci. 2019;13:489. doi: 10.3389/fncel.2019.00489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00489</ArticleId><ArticleId IdType="pmc">PMC6854036</ArticleId><ArticleId IdType="pubmed">31787882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm F., Winkler U., Morawski M., Jager C., Reinecke L., Rossner M.J., Hirrlinger P.G., Hirrlinger J. The human ubiquitin C promoter drives selective expression in principal neurons in the brain of a transgenic mouse line. Neurochem. Int. 2011;59:976&#x2013;980. doi: 10.1016/j.neuint.2011.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2011.07.008</ArticleId><ArticleId IdType="pubmed">21802467</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., Mills K., Mitsumoto H., Nodera H., Shefner J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera M.O., Beron W., Colombo M.I. The actin cytoskeleton participates in the early events of autophagosome formation upon starvation induced autophagy. Autophagy. 2012;8:1590&#x2013;1603. doi: 10.4161/auto.21459.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.21459</ArticleId><ArticleId IdType="pmc">PMC3494589</ArticleId><ArticleId IdType="pubmed">22863730</ArticleId></ArticleIdList></Reference><Reference><Citation>Izdebska M., Zielinska W., Halas-Wisniewska M., Grzanka A. Involvement of Actin in Autophagy and Autophagy-Dependent Multidrug Resistance in Cancer. Cancers. 2019;11:1209. doi: 10.3390/cancers11081209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11081209</ArticleId><ArticleId IdType="pmc">PMC6721626</ArticleId><ArticleId IdType="pubmed">31434275</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., Miller T.M., Cashman N.R., Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl. Acad. Sci. USA. 2008;105:4022&#x2013;4027. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D&#x2019;Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. USA. 2014;111:E4439&#x2013;E4448. doi: 10.1073/pnas.1405752111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405752111</ArticleId><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero V., Manfredi G. Mitochondrial Transport and Turnover in the Pathogenesis of Amyotrophic Lateral Sclerosis. Biology. 2019;8:36. doi: 10.3390/biology8020036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020036</ArticleId><ArticleId IdType="pmc">PMC6627920</ArticleId><ArticleId IdType="pubmed">31083575</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134 Pt 9:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Salachas F., Cazeneuve C., Gordon P., Bricka B., Camuzat A., Guillot-Noel L., Russaouen O., Bruneteau G., Pradat P.F., et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: Genotype-phenotype correlations. J. Med. Genet. 2010;47:554&#x2013;560. doi: 10.1136/jmg.2010.077180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2010.077180</ArticleId><ArticleId IdType="pubmed">20577002</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Boillee S., Chabrol E., Camu W., Cazeneuve C., Salachas F., Pradat P.F., Danel-Brunaud V., Vandenberghe N., Corcia P., et al. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol. Aging. 2011;32:557.e11&#x2013;557.e13. doi: 10.1016/j.neurobiolaging.2010.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.11.005</ArticleId><ArticleId IdType="pubmed">21220178</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., Da Barroca S., Cazeneuve C., Salachas F., Pradat P.F., Danel-Brunaud V., Vandenberghe N., Lacomblez L., Le Forestier N., Bruneteau G., et al. Questioning on the role of D amino acid oxidase in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2010;107:E107. doi: 10.1073/pnas.1006190107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006190107</ArticleId><ArticleId IdType="pmc">PMC2900698</ArticleId><ArticleId IdType="pubmed">20538972</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S., De Septenville A., Teyssou E., Daniau M., Camuzat A., Albert M., LeGuern E., Galimberti D., Brice A., Marie Y., et al. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2014;35:2882.e13&#x2013;2882.e15. doi: 10.1016/j.neurobiolaging.2014.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.016</ArticleId><ArticleId IdType="pubmed">25158920</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Takeda T., Lebon V., Boillee S., Doukoure B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., LeGuern E., et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: Genetics and neuropathology. Acta Neuropathol. 2013;125:511&#x2013;522. doi: 10.1007/s00401-013-1090-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1090-0</ArticleId><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Vandenberghe N., Moigneu C., Boillee S., Couratier P., Meininger V., Pradat P.F., Salachas F., Leguern E., Millecamps S. Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:1213.e9&#x2013;1213.e12. doi: 10.1016/j.neurobiolaging.2013.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.023</ArticleId><ArticleId IdType="pubmed">24360741</ArticleId></ArticleIdList></Reference><Reference><Citation>Schorpp M., Jager R., Schellander K., Schenkel J., Wagner E.F., Weiher H., Angel P. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 1996;24:1787&#x2013;1788. doi: 10.1093/nar/24.9.1787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/24.9.1787</ArticleId><ArticleId IdType="pmc">PMC145851</ArticleId><ArticleId IdType="pubmed">8650001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zennou V., Serguera C., Sarkis C., Colin P., Perret E., Mallet J., Charneau P. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 2001;19:446&#x2013;450. doi: 10.1038/88115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88115</ArticleId><ArticleId IdType="pubmed">11329014</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike Winer L.S., Wu M. Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. PLoS ONE. 2014;9:e109916. doi: 10.1371/journal.pone.0109916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109916</ArticleId><ArticleId IdType="pmc">PMC4215881</ArticleId><ArticleId IdType="pubmed">25360519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55&#x2013;63. doi: 10.1016/0022-1759(83)90303-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(83)90303-4</ArticleId><ArticleId IdType="pubmed">6606682</ArticleId></ArticleIdList></Reference><Reference><Citation>Barneoud P., Lolivier J., Sanger D.J., Scatton B., Moser P. Quantitative motor assessment in FALS mice: A longitudinal study. Neuroreport. 1997;8:2861&#x2013;2865. doi: 10.1097/00001756-199709080-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199709080-00012</ArticleId><ArticleId IdType="pubmed">9376520</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans T.M., Van Remmen H., Purkar A., Mahesula S., Gelfond J.A., Sabia M., Qi W., Lin A.L., Jaramillo C.A., Haskins W.E. Microwave &amp; Magnetic (M(2)) Proteomics of a Mouse Model of Mild Traumatic Brain Injury. Transl. Proteom. 2014;3:10&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492171</ArticleId><ArticleId IdType="pubmed">26157646</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 1963;17:208&#x2013;212. doi: 10.1083/jcb.17.1.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.17.1.208</ArticleId><ArticleId IdType="pmc">PMC2106263</ArticleId><ArticleId IdType="pubmed">13986422</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>